Common stock, par value $0.0001 per share
- Symbol
- NIKI
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Niki BioSolutions, Inc.
NIKINASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. We are filing this report to disclose our corporate PowerPoint presentation. The presentation is furnished as an exhibit to this Current Report on Form 8-K. Neither this report nor the exhibit attached hereto constitute an offer to sell, or the solicitation of an offer to buy our securities, nor shall there be any sale of our securities in any state or jurisdiction in which…
Company context
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. For more information, please visit the company’s website at www.aptorumgroup.com.
Current securities
Historical securities (1)
Registered securities in this filing
Niki BioSolutions, Inc. · 8-K · Filed 2026-09-14
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
We are filing
this report to disclose our corporate PowerPoint presentation. The presentation is furnished as an exhibit to this Current Report
on Form 8-K.
Neither this report nor the exhibit attached hereto
constitute an offer to sell, or the solicitation of an offer to buy our securities, nor shall there be any sale of our securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or jurisdiction.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Description
───────────────────────────────────────────────────────────────────────────
99.1 Presentation
104 Cover Page Interactive Data File, formatted in Inline XBRL
Filed exhibits (1)
EX-99.1 2 ea030533401ex99-1.htm PRESENTATION Exhibit 99.1 Alidad Mireskandari, Ph. D. President & COO H.C. Wainwright Global Investment Conference, September 2026 NASDAQ: NIKI Forward-Looking Statements Legal Disclaimer This presentation contains summary information about Niki BioSolutions, Aptorum Group Limited and DiamiR Biosciences Corp. (collectively, the "Companies") as of the date hereof. The information in this presentation is of general background and contains an overview and summary of certain data selected by the management of the Companies. It does not purport to be complete. This presentation is not a prospectus, disclosure document, or offering document under the law of any jurisdiction. It is for informational purposes only. This presentation is not investment or financial product advice (nor tax, accounting, or legal advice) and is not intended to be used as the basis for making an investment decision. A recipient must make their own independent investigations, consideration and evaluation of the Companies and the Companies recommend that investors should obtain their own professional advice before making any investment decisions in the Companies. This presenta…
Open exhibit ↗